We design nanoparticles to breach biological barriers
“There are many clinical challenges that still require nanomedicine-based solutions.”
We design nanoparticles for the aim of breaching biological barriers in applications related to Women’s Health. To ensure the clinical translation of the novel therapies designed in our lab, we develop humanized organ-on-a-chip models for preclinical evaluation of nanoparticles.
Dr. Hagar Labouta
Keenan Research chair of Nanomedicine and
Assistant Professor at The University of Toronto
Find out about the dedicated work and contributions, awards, and the career highlights of our principal investigator
Interdisciplinary Research
We are an interdisciplinary team that works at the boundries of Nanoscience, Microfluidics & Molecular biology